Nephrocare Health IPO: Complete Analysis, Price Band, GMP, Dates, Subscription & Should You Apply?
Complete Nephrocare Health IPO guide: price band ₹438–₹460, IPO dates (Dec 10–12, 2025), lot size, financials, GMP, allotment & expert IPO Ji analysis to help you decide.
The Nephrocare Health Services Ltd. IPO is one of the most significant healthcare IPOs of 2025, attracting strong attention from retail investors, HNIs, and institutional players. As India witnesses rapid growth in chronic kidney disease (CKD) cases and rising demand for dialysis treatment, the IPO of the country’s largest dialysis chain has generated widespread market interest.
In this comprehensive guide, IPO Ji provides a fully verified, SEO-optimized, and deeply analytical breakdown of the Nephrocare Health IPO, covering every essential detail such as IPO dates, price band, issue size, GMP, objectives of the issue, financials, valuation, risks, long-term prospects, subscription status, and expert commentary.
What is Nephrocare Health Services Ltd.? A Detailed Overview
Nephrocare Health Services Ltd., incorporated in 2010, is India’s and Asia’s largest dialysis service provider. The company operates a vast network of dialysis clinics across the country and internationally, particularly in underserved regions lacking advanced kidney care.
By September 30, 2025, Nephrocare had:
- 519 operational dialysis clinics
- Presence across 21 Indian states & 4 union territories
- Clinics in Philippines, Nepal, and Uzbekistan
- One of the world’s largest single-site dialysis facilities (Uzbekistan)
- 5,562 dialysis machines deployed
- 31,046 patients treated in FY26 (till September)
- 1.59 million dialysis sessions in the first six months of FY26
The company’s extensive presence in Tier II and Tier III cities (77.53% of centers) highlights its strong penetration into underserved kidney-care markets, making it a leader not just in size but also in accessibility.
Nephrocare Health IPO Details: Everything You Need to Know
This section covers the complete IPO structure, pricing, dates, and listing details, which are among the most searched keywords for investors.
Nephrocare Health IPO Key Highlights (2025)
- IPO Open Date: December 10, 2025
- IPO Close Date: December 12, 2025
- Listing Date: December 17, 2025 (Tentative)
- Price Band: ₹438 – ₹460 per share
- Face Value: ₹2 per share
- Issue Size: ₹871.05 crore
- Fresh Issue: ₹353.40 crore
- Offer for Sale (OFS): ₹517.64 crore
- Lot Size: 32 shares
- Listing Exchanges: BSE & NSE
- Issue Type: Book-Building IPO
- Registrar: Kfin Technologies Ltd.
- Lead Managers: ICICI Securities, IIFL Capital, Ambit, Nomura
Nephrocare Health IPO Lot Size & Investment Requirements
Investors often search for “Nephrocare IPO lot size”, “minimum investment”, and “HNI lot size”. Here's the complete breakdown.
This makes the IPO affordable for retail investors, while attracting HNI participation due to its sector relevance and growth prospects.
Nephrocare Health IPO Timeline (2025)
Investors searching for Nephrocare IPO allotment date, Nephrocare IPO listing date, or Nephrocare IPO refund status will find this section highly relevant.
Nephrocare Health Financial Performance:
Strong financials are a major driver behind the enthusiasm for this IPO. Below is a textual, insight-heavy analysis that helps rank for search queries like Nephrocare Health financials, Nephrocare IPO profit, Nephrocare revenue.
Revenue Growth
Between FY23 and FY25, Nephrocare’s consolidated revenue grew from ₹443.26 crore to ₹769.92 crore, reflecting a strong double-digit CAGR driven by expansion into new regions and consistently rising patient volumes.
Profitability Surge
The company reported:
- PAT of ₹35.13 crore in FY24
- PAT of ₹67.10 crore in FY25, up 91% YoY
- Positive PAT in H1 FY26 at ₹14.23 crore
This strong upward trend demonstrates rising operating efficiency and maturing unit economics.
EBITDA Expansion
EBITDA improved from ₹48.60 crore in FY23 to ₹166.64 crore in FY25, indicating:
- Better capacity utilization
- Superior operational control
- Improved cost optimization across centers
Debt Management
Total borrowings reduced from ₹243.37 crore in FY23 to ₹207.04 crore by Sep 2025, with further debt repayment planned using IPO proceeds.
Broader Financial Metrics
- ROE: 13.45%
- ROCE: 18.67%
- PAT Margin: 8.88%
- EBITDA Margin: 22.05%
These place Nephrocare among the more efficient healthcare service providers in the Indian market.
Nephrocare Health IPO Valuation Analysis (Pre & Post Issue)
Understanding valuation is essential for ranking on keywords like Nephrocare IPO valuation, Nephrocare P/E, Nephrocare EPS.
The post-issue P/E appears high, suggesting that the company is priced with expectations of strong long-term growth, similar to other high-quality healthcare service providers.
Competitive Strengths of Nephrocare Health
Nephrocare stands out due to:
- India’s largest dialysis chain and Asia’s biggest dialysis service network
- Asset-light model enabling rapid clinic expansion
- Extensive presence in underserved Tier II & Tier III cities
- Tie-ups with leading hospitals like Max, Fortis, Wockhardt, Paras, CMRI
- Strong technological and clinical processes
- Backed by renowned institutional investors
- Sustained financial performance and robust EBITDA margins
Each of these points supports search queries like Nephrocare business model, Nephrocare strengths, and Nephrocare competitive advantage.
Objects of the Issue: Where Will Nephrocare Use IPO Funds?
This ensures:
- Expansion into new geographies
- Strengthening of balance sheet
- Enhanced operational capabilities
Nephrocare IPO GMP (Grey Market Premium)
GMP plays a critical role in investor sentiment.
You can check the daily updated Nephrocare grey market premium on the IPO Ji GMP dashboard to track premium movement, demand strength, and expected listing price.
FAQs on Nephrocare Health IPO
1. What is the Nephrocare Health IPO price band?
₹438 to ₹460 per share.
2. What is the Nephrocare IPO lot size?
32 shares per lot.
3. When is the Nephrocare IPO allotment date?
December 15, 2025.
4. When will Nephrocare Health IPO list on NSE & BSE?
December 17, 2025 (tentative).
5. What is the Nephrocare IPO GMP today?
Check the IPO Ji live GMP tracker for real-time updates.
6. Should I apply for Nephrocare Health IPO?
Suitable for investors seeking long-term exposure to the healthcare and dialysis service market.
